查看购物车
  • Traditional Chinese
  • English
2021-2031 年欧洲医疗第二意见市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843415

2021-2031 年欧洲医疗第二意见市场报告（范围、细分、动态和竞争分析）

Europe Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 116 Pages | 订单完成后即时交付

价格

预计欧洲医疗第二意见市场将大幅成长，到 2031 年将达到约 47.1417 亿美元，高于 2023 年的 16.5244 亿美元，预测期内的年复合成长率(CAGR) 为 14.0%。

执行摘要和市场分析

欧洲医疗第二诊疗意见市场的成长受到多种因素的推动，包括慢性病发病率的上升以及医疗诈欺案件的增加。此外，良好的监管环境、本土企业的存在以及提供第二诊疗意见服务的诊所数量的不断增加，也为该市场带来了许多益处。

市场区隔

市场可以根据医疗条件和服务提供者进行细分。

1. 依疾病类型划分：市场分为几类，包括癌症、骨科疾病、心臟疾病、神经系统疾病、肾臟疾病、血液系统疾病、慢性阻塞性肺病 (COPD)、器官移植等。值得注意的是，癌症领域在 2023 年占据了最大的市场。

2. 按服务提供者划分：市场也按服务提供者细分，包括医院、健康保险公司和线上服务。 2023年，医院占据了该细分市场的最大份额。

市场展望

第二医疗意见对于向患者提供有关其治疗方案的全面资讯至关重要。它们有助于澄清针对单一病症的多种治疗建议可能引起的困惑。此外，获得第二医疗意见可以验证诊断，从而提高治疗的准确性。重视改善治疗效果是市场成长的重要驱动力。鑑于各种治疗方法都可能产生副作用，获得合格医疗保健专业人员的第二医疗意见至关重要，尤其是在重症病例中。根据世界卫生组织 (WHO) 的数据，不安全的医疗行为每年导致全球超过 300 万人死亡。 2022 年，全球报告的癌症相关死亡人数约为 970 万，凸显了对准确诊断和有效治疗方案的迫切需求。癌症和其他慢性疾病的日益普及是推动第二医疗意见需求的关键因素。

国家洞察

欧洲医疗第二意见市场涵盖多个国家，特别是德国、英国、法国、义大利、西班牙等。德国是2023年领先的市场。

在德国，由于慢性病（尤其是癌症）发生率的上升，预计市场将大幅扩张。癌症是导致发病和死亡的主要原因。世界卫生组织报告称，2020年德国新增癌症病例628,519例，癌症相关死亡病例252,065例。这一令人担忧的趋势导致对精准诊断和治疗方案的需求日益增长，促使癌症患者更频繁地寻求第二诊疗意见。

德国政府已经认识到第二诊疗意见在医疗保健领域的重要性。 《德国病患权利宪章》保障病患寻求第二诊疗意见的权利，并要求医疗机构配合此类要求。德国知名的医疗机构，例如IMC Intermed-Consult，为寻求第二诊疗意见的国际患者提供全面的服务。此外，德国健康中心 (Germany Health) 也为包括癌症和骨科手术在内的各种疾病提供独立医学专家的评估。

本地市场参与者也为德国医疗第二意见市场的成长做出了贡献。例如，腓特烈港诊所推出了一项远距咨询服务，让国际患者能够以可负担的价格获得有价值的资讯和替代治疗方案。

公司简介

欧洲医疗第二意见市场的主要参与者包括 Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、2nd.MD、Axa SA、Teladoc Health Inc、Included Health, Inc. 和 Royal Doctors 等。这些公司正在采用各种策略，包括扩张、产品创新和併购，以增强其产品服务并提升其市场占有率。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：欧洲医疗第二意见市场－关键市场动态

  • 市场驱动因素
    • 越来越重视更好的治疗效果
    • 医疗成本优化的偏好日益增强
  • 市场限制
    • 新兴国家对第二医疗意见缺乏认识且不愿采纳
  • 市场机会
    • 远距医疗技术合作日益增多
  • 未来趋势
    • 医疗咨询服务数位化
  • 驱动因素和限制因素的影响：

第五章：医疗第二意见市场－欧洲分析

  • 2021-2031年欧洲医疗第二意见市场收入
  • 欧洲医疗第二意见市场预测分析

第六章：欧洲医疗第二意见市场分析－依条件

  • 癌症
  • 骨科疾病
  • 心臟疾病
  • 神经系统疾病
  • 肾臟疾病
  • 血液系统疾病
  • 慢性阻塞性肺病
  • 器官移植
  • 其他的

第七章：欧洲医疗第二意见市场分析－依服务提供者

  • 医院
  • 健康保险公司
  • 线上服务

第八章：欧洲医疗第二意见市场－国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第九章：产业格局

  • 概述
  • 医疗第二意见市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十章：公司简介

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第 11 章：附录

Product Code: TIPRE00025236

The European medical second opinion market is projected to grow significantly, reaching approximately USD 4,714.17 million by 2031, up from USD 1,652.44 million in 2023, with a compound annual growth rate (CAGR) of 14.0% during the forecast period.

Executive Summary and Market Analysis

The growth of the medical second opinion market in Europe is driven by several factors, including the rising incidence of chronic diseases and an increase in healthcare fraud cases. The market benefits from a favorable regulatory environment, the presence of local players, and a growing number of clinics that offer second-opinion services.

Market Segmentation

The market can be segmented based on medical conditions and service providers.

1. By Condition: The market is divided into several categories, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals held the largest share of this segment.

Market Outlook

Medical second opinions are crucial for providing patients with comprehensive information regarding their treatment options. They help clarify the confusion that may arise from multiple treatment recommendations for a single condition. Additionally, obtaining a second opinion can validate diagnoses, thereby enhancing treatment accuracy. The emphasis on improving treatment outcomes is a significant driver of market growth. Given the potential adverse effects of various treatments, obtaining a second opinion from a qualified healthcare professional is essential, especially in critical cases. According to the World Health Organization (WHO), unsafe medical practices contribute to over 3 million deaths annually worldwide. In 2022, approximately 9.7 million cancer-related deaths were reported globally, highlighting the urgent need for accurate diagnoses and effective treatment options. The increasing prevalence of cancer and other chronic diseases is a key factor propelling the demand for medical second opinions.

Country Insights

The European medical second opinion market includes several countries, notably Germany, the UK, France, Italy, Spain, and others. Germany was the leading market in 2023.

In Germany, the market is expected to expand significantly due to the rising rates of chronic diseases, particularly cancer, which is a leading cause of morbidity and mortality. The WHO reported 628,519 new cancer cases and 252,065 cancer-related deaths in Germany in 2020. This alarming trend has led to a heightened demand for accurate diagnostics and treatment options, prompting cancer patients to seek second opinions more frequently.

The German government has recognized the importance of second opinions in healthcare. The "Charter of Patients' Rights in Germany" ensures that patients have the right to seek a second medical opinion, mandating that healthcare providers cooperate with such requests. Notable healthcare providers in Germany, such as IMC Intermed-Consult, offer comprehensive services for international patients seeking second opinions. Additionally, Germany Health provides evaluations from independent medical experts for various conditions, including cancer and orthopedic surgeries.

Local market players are also contributing to the growth of the medical second opinion market in Germany. For instance, the Clinic of Friedrichshafen has introduced a tele-counseling service that allows international patients to access valuable information and alternative treatment options affordably.

Company Profiles

Key players in the European medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Europe Medical Second Opinion Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Growing Emphasis on Better Treatment Outcomes
    • 4.1.2 Increasing Preference for Healthcare Cost Optimization
  • 4.2 Market Restraints
    • 4.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 4.3 Market Opportunities
    • 4.3.1 Rising Collaborations in Telemedicine Technologies
  • 4.4 Future Trends
    • 4.4.1 Digitalization of Medical Consulting Services
  • 4.5 Impact of Drivers and Restraints:

5. Medical Second Opinion Market - Europe Analysis

  • 5.1 Europe Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Medical Second Opinion Market Forecast Analysis

6. Europe Medical Second Opinion Market Analysis - by Condition

  • 6.1 Cancer
    • 6.1.1 Overview
    • 6.1.2 Cancer: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Orthopedic Disorders
    • 6.2.1 Overview
    • 6.2.2 Orthopedic Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Cardiac Disorders
    • 6.3.1 Overview
    • 6.3.2 Cardiac Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Neurological Disorders
    • 6.4.1 Overview
    • 6.4.2 Neurological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Nephrological Disorders
    • 6.5.1 Overview
    • 6.5.2 Nephrological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Hematological Blood Disorders
    • 6.6.1 Overview
    • 6.6.2 Hematological Blood Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 COPD
    • 6.7.1 Overview
    • 6.7.2 COPD: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Organ Transplant
    • 6.8.1 Overview
    • 6.8.2 Organ Transplant: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Europe Medical Second Opinion Market Analysis - by Service Provider

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Hospitals: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Health Insurance Companies
    • 7.2.1 Overview
    • 7.2.2 Health Insurance Companies: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Online Services
    • 7.3.1 Overview
    • 7.3.2 Online Services: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Medical Second Opinion Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Medical Second Opinion Market Overview
    • 8.1.2 Europe Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.1 Europe Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.2 Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.2.1 Germany: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.2.2 Germany: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.3 United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.3.1 United Kingdom: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.3.2 United Kingdom: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.4 France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.4.1 France: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.4.2 France: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.5 Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.5.1 Italy: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.5.2 Italy: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.6 Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.6.1 Spain: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.6.2 Spain: Europe Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.7 Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.7.1 Rest of Europe: Europe Medical Second Opinion Market Share - by Condition
        • 8.1.2.7.2 Rest of Europe: Europe Medical Second Opinion Market Share - by Service Provider

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Medical Second Opinion Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Second Opinion International
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elite Medical Services
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 The Cigna Group
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Helsana
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 WorldCare
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Vidal Health Insurance TPA Pvt Ltd
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 2nd.MD
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Axa SA
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Teladoc Health Inc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Included Health, Inc.
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Royal Doctors
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 List of Abbreviations

List Of Tables

  • Table 1. Europe Medical Second Opinion Market Segmentation
  • Table 2. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Condition
  • Table 4. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Provider
  • Table 5. Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 6. Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 7. Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 8. United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 9. United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 10. France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 11. France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 12. Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 13. Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 14. Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 15. Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 16. Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 17. Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 18. Recent Organic Growth Strategies in Medical Second Opinion Market
  • Table 19. Recent Inorganic Growth Strategies in the Medical Second Opinion Market
  • Table 20. List of Abbreviations

List Of Figures

  • Figure 1. Europe Medical Second Opinion Market Segmentation - Country
  • Figure 2. Europe Medical Second Opinion Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 6. Cancer: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Orthopedic Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Cardiac Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Neurological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Nephrological Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Hematological Blood Disorders: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. COPD: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Organ Transplant: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Europe Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 16. Hospitals: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Health Insurance Companies: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Online Services: Europe Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Europe Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 20. Germany: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 21. United Kingdom: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. France: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Italy: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Spain: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Rest of Europe: Europe Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Growth Strategies in Medical Second Opinion Market